Halkidiki Early Harvest Olive Oil to be used in Alzheimer’s clinical tests (26/05/2017)
Scientists suspected for some years now that substances in olive oil, especially phenols help fight the development of neurological disorders that lead to diseases like Alzheimer’s and Parkinson’s.
Recent findings however with the help offered by the development of the NMR (Nuclear Magnetic Resonance) technique that shows accurately the phenolic content in olive oil, opened a new path. Lab tests using high phenolic olive oil on rodents showed that not only the development of the Alzheimer’s disease stopped but the brain condition gradually returned to its original healthy state!
The enthusiasm amongst the scientific community was such that they wanted to try to confirm if possible the lab findings in clinical test on humans. After sorting all issues involved with this project, researchers are ready and in the next few months clinical tests using Halkidiki High Phenolic Olive Oil, like ELEONES Early Harvest, will begin on humans that will last for two years.
The Halkidiki High Phenolic Olive Oil was selected for its unique combination of beneficial substances and scientists believe it has the best chances of achieving the desired results.
It is noted that nearly 44million people in the world have Alzheimer’s , when only 1-in-4 people with the disease have been diagnosed. The global cost of Alzheimer’s is estimated at 605billion US dollars. At the moment millions of US dollars were spent on research by pharmaceutical companies for new drugs that did not even come close to the results achieved in lab tests by high phenolic olive oil.
Sources: Alzheimer’s Association Facts and Figures, Center for Disease Control, Alzheimer’s Disease International’s World Report